Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for SRBZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 -10.75M
March 31, 2026 -21.14M
December 31, 2025 3.149M
September 30, 2025
December 31, 2024 -6.844M
September 30, 2024 -2.293M
June 30, 2024 0.9592M
March 31, 2024 -13.59M
December 31, 2023 9.131M
September 30, 2023 -2.069M
June 30, 2023 29.04M
March 31, 2023 1.989M
December 31, 2022 2.890M
September 30, 2022 -2.006M
June 30, 2022 -21.32M
March 31, 2022 5.709M
December 31, 2021 -8.432M
September 30, 2021 -9.460M
June 30, 2021 -21.26M
March 31, 2021 -1.556M
December 31, 2020 4.380M
September 30, 2020 1.736M
June 30, 2020 -15.95M
March 31, 2020 16.02M
December 31, 2019 2.926M
Date Value
September 30, 2019 4.846M
June 30, 2019 -1.171M
March 31, 2019 -0.5632M
December 31, 2018 10.23M
September 30, 2018 0.0003M
June 30, 2018 -10.13M
March 31, 2018 -1.374M
December 31, 2017 0.087M
September 30, 2017 -0.6124M
June 30, 2017
March 31, 2017
December 31, 2016 -18.36M
September 30, 2016 -0.2679M
June 30, 2016
March 31, 2016
December 31, 2015 0.0657M
September 30, 2015 -0.0011M
June 30, 2015 -11.06M
March 31, 2015 1.438M
December 31, 2014 -0.0812M
September 30, 2014 -0.9406M
June 30, 2014 -8.978M
March 31, 2014 -0.9454M
December 31, 2013 0.6452M
September 30, 2013 0.3459M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Merck KGaA -920.17M
Scientific Industries, Inc. 0.00
Carl Zeiss Meditec AG --
Drägerwerk AG & Co. KGaA -50.42M
Polarean Imaging Plc --